These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

667 related items for PubMed ID: 15024047

  • 1. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination.
    Bonifaz LC, Bonnyay DP, Charalambous A, Darguste DI, Fujii S, Soares H, Brimnes MK, Moltedo B, Moran TM, Steinman RM.
    J Exp Med; 2004 Mar 15; 199(6):815-24. PubMed ID: 15024047
    [Abstract] [Full Text] [Related]

  • 2. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
    Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, Steinman RM.
    J Exp Med; 2002 Dec 16; 196(12):1627-38. PubMed ID: 12486105
    [Abstract] [Full Text] [Related]

  • 3. Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo.
    Volckmar J, Knop L, Hirsch T, Frentzel S, Erck C, van Ham M, Stegemann-Koniszewski S, Bruder D.
    J Vis Exp; 2021 Feb 05; (168):. PubMed ID: 33616089
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.
    Grossmann C, Tenbusch M, Nchinda G, Temchura V, Nabi G, Stone GW, Kornbluth RS, Uberla K.
    BMC Immunol; 2009 Aug 03; 10():43. PubMed ID: 19650904
    [Abstract] [Full Text] [Related]

  • 5. Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells.
    Adams EW, Ratner DM, Seeberger PH, Hacohen N.
    Chembiochem; 2008 Jan 25; 9(2):294-303. PubMed ID: 18186095
    [Abstract] [Full Text] [Related]

  • 6. Targeting the antigen encoded by adenoviral vectors to the DEC205 receptor modulates the cellular and humoral immune response.
    Tenbusch M, Nchinda G, Storcksdieck genannt Bonsmann M, Temchura V, Überla K.
    Int Immunol; 2013 Apr 25; 25(4):247-58. PubMed ID: 23184617
    [Abstract] [Full Text] [Related]

  • 7. The human cancer antigen mesothelin is more efficiently presented to the mouse immune system when targeted to the DEC-205/CD205 receptor on dendritic cells.
    Wang B, Kuroiwa JM, He LZ, Charalambous A, Keler T, Steinman RM.
    Ann N Y Acad Sci; 2009 Sep 25; 1174():6-17. PubMed ID: 19769731
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity.
    Tsuji T, Matsuzaki J, Kelly MP, Ramakrishna V, Vitale L, He LZ, Keler T, Odunsi K, Old LJ, Ritter G, Gnjatic S.
    J Immunol; 2011 Jan 15; 186(2):1218-27. PubMed ID: 21149605
    [Abstract] [Full Text] [Related]

  • 11. Targeting dendritic cells in humanized mice receiving adoptive T cells via monoclonal antibodies fused to Flu epitopes.
    Graham JP, Authie P, Yu CI, Zurawski SM, Li XH, Marches F, Flamar AL, Acharya A, Banchereau J, Palucka AK.
    Vaccine; 2016 Sep 22; 34(41):4857-4865. PubMed ID: 27595442
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation.
    Birkholz K, Schwenkert M, Kellner C, Gross S, Fey G, Schuler-Thurner B, Schuler G, Schaft N, Dörrie J.
    Blood; 2010 Sep 30; 116(13):2277-85. PubMed ID: 20566893
    [Abstract] [Full Text] [Related]

  • 14. Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative study.
    Cruz LJ, Rosalia RA, Kleinovink JW, Rueda F, Löwik CW, Ossendorp F.
    J Control Release; 2014 Oct 28; 192():209-18. PubMed ID: 25068703
    [Abstract] [Full Text] [Related]

  • 15. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A.
    Idoyaga J, Lubkin A, Fiorese C, Lahoud MH, Caminschi I, Huang Y, Rodriguez A, Clausen BE, Park CG, Trumpfheller C, Steinman RM.
    Proc Natl Acad Sci U S A; 2011 Feb 08; 108(6):2384-9. PubMed ID: 21262813
    [Abstract] [Full Text] [Related]

  • 16. Targeting of antigens to activated dendritic cells in vivo cures metastatic melanoma in mice.
    Mahnke K, Qian Y, Fondel S, Brueck J, Becker C, Enk AH.
    Cancer Res; 2005 Aug 01; 65(15):7007-12. PubMed ID: 16061687
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.